Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
2001546 citationsLynn C. Hartmann, Thomas A. Sellers et al.JNCI Journal of the National Cancer Instituteprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of T. Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Frank more than expected).
This network shows the impact of papers produced by T. Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Frank. The network helps show where T. Frank may publish in the future.
Co-authorship network of co-authors of T. Frank
This figure shows the co-authorship network connecting the top 25 collaborators of T. Frank.
A scholar is included among the top collaborators of T. Frank based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with T. Frank. T. Frank is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Hartmann, Lynn C., Thomas A. Sellers, Daniel J. Schaid, et al.. (2001). Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers. JNCI Journal of the National Cancer Institute. 93(21). 1633–1637.546 indexed citations breakdown →
Frank, T., et al.. (1999). Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).. PubMed. 37(9). 449–55.6 indexed citations
7.
Berchuck, Andrew, Michael E. Carney, Jonathan Lancaster, et al.. (1998). Frequency of germline and somatic BRCA1 mutations in ovarian cancer.. PubMed. 4(10). 2433–7.137 indexed citations
8.
Caduff, Rosemarie, et al.. (1997). Molecular analysis in endometrial cancer.. PubMed. 81. 219–27.6 indexed citations
Frank, T., et al.. (1996). Analysis of paraffin sections of Crohn's disease for Mycobacterium paratuberculosis using polymerase chain reaction.. PubMed. 9(1). 32–5.33 indexed citations
15.
Caduff, Rosmarie, Carolyn M. Johnston, & T. Frank. (1995). Mutations of the Ki-ras oncogene in carcinoma of the endometrium.. PubMed. 146(1). 182–8.63 indexed citations
16.
Merajver, Sofía D., T. Frank, Therese Pham, et al.. (1995). Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.. PubMed. 1(5). 539–44.73 indexed citations
Frank, T., et al.. (1987). Cytomegalovirus infection of the thyroid in immunocompromised adults.. PubMed. 60(1). 1–8.33 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.